NCT06426823Completed
The Role of GIP in Postprandial Splanchnic Blood Flow Distribution and Metabolism in Patients With Type 2 Diabetes
Source: ClinicalTrials.gov · Last updated 18 Mar 2026
Brief summary (registry, in English)
This project will describe the mechanisms of action and the relative contributions of GIP to changes in gastrointestinal blood flow induced by oral glucose and endogenous GIP with the use of a receptor antagonists GIP(3-30)NH2 in patients with type 2 diabetes.
- Status (registry)
- Completed
- Study type
- Interventional
- Enrollment
- 10 (actual)
- First submitted
- 6 May 2024
- Start date
- 1 Nov 2023
- Primary completion date
- 16 Mar 2026
- Lead sponsor
- University of Copenhagen
- Diseases
- Type 2 diabetes
- NCT number
- NCT06426823
What you commit to
- Study type: Interventional
- Participants enrolled: 10
- From 1 Nov 2023 to the primary completion date, 16 Mar 2026
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Not MRI-compatible implants
Other illness
- Hypertension
- Other conditions that could be expected to affect the primary or secondary outcomes
Other
- Claustrophobia
- Abnormal kidney or liver function
- Anemia
- Planned weight loss or change in diet
Who the study is looking for
- Type 2 diabetes
- BMI 20-35 kg/m\^2
- Age 20-80
Age in the registry: 20 years to 80 years · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Rigshospitalet Coordinator of this site? Confirm its status | Copenhagen | Denmark | Unknown status |
Related publications
- Reproducibility of Splanchnic Blood Flow Measured Using Phase-Contrast MRI.NMR Biomed · 2026 · PMID 42373095
- GIP contributes to postprandial regulation of splanchnic blood supply in humans with type 2 diabetes: a randomised, single-blinded, placebo-controlled, crossover study.Diabetologia · 2026 · PMID 42393405
This page is information, not medical advice. Discuss any trial with your doctor.